West Pharmaceutical Services Operating Income 2010-2025 | WST

West Pharmaceutical Services annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • West Pharmaceutical Services operating income for the quarter ending March 31, 2025 was $107M, a 12.87% decline year-over-year.
  • West Pharmaceutical Services operating income for the twelve months ending March 31, 2025 was $0.554B, a 13.89% decline year-over-year.
  • West Pharmaceutical Services annual operating income for 2024 was $0.57B, a 15.7% decline from 2023.
  • West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
West Pharmaceutical Services Annual Operating Income
(Millions of US $)
2024 $570
2023 $676
2022 $734
2021 $752
2020 $407
2019 $297
2018 $240
2017 $226
2016 $195
2015 $129
2014 $182
2013 $162
2012 $135
2011 $110
2010 $91
2009 $98
West Pharmaceutical Services Quarterly Operating Income
(Millions of US $)
2025-03-31 $107
2024-12-31 $160
2024-09-30 $161
2024-06-30 $126
2024-03-31 $123
2023-12-31 $161
2023-09-30 $177
2023-06-30 $183
2023-03-31 $155
2022-12-31 $130
2022-09-30 $186
2022-06-30 $228
2022-03-31 $190
2021-12-31 $184
2021-09-30 $181
2021-06-30 $211
2021-03-31 $176
2020-12-31 $116
2020-09-30 $99
2020-06-30 $104
2020-03-31 $88
2019-12-31 $78
2019-09-30 $67
2019-06-30 $81
2019-03-31 $71
2018-12-31 $66
2018-09-30 $61
2018-06-30 $60
2018-03-31 $53
2017-12-31 $60
2017-09-30 $63
2017-06-30 $42
2017-03-31 $61
2016-12-31 $53
2016-09-30 $51
2016-06-30 $61
2016-03-31 $30
2015-12-31 $45
2015-09-30 $-4
2015-06-30 $39
2015-03-31 $48
2014-12-31 $45
2014-09-30 $44
2014-06-30 $54
2014-03-31 $39
2013-12-31 $37
2013-09-30 $40
2013-06-30 $43
2013-03-31 $43
2012-12-31 $32
2012-09-30 $26
2012-06-30 $36
2012-03-31 $42
2011-12-31 $27
2011-09-30 $26
2011-06-30 $28
2011-03-31 $29
2010-12-31 $6
2010-09-30 $25
2010-06-30 $31
2010-03-31 $29
2009-12-31 $22
2009-09-30 $26
2009-06-30 $29
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.999B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.183B 21.78
Becton Dickinson (BDX) United States $49.173B 12.18
Cardinal Health (CAH) United States $39.193B 20.53
Straumann Holding AG (SAUHY) Switzerland $20.634B 0.00
Cooper (COO) United States $14.185B 18.28
Align Technology (ALGN) United States $13.524B 26.85
Henry Schein (HSIC) United States $8.847B 15.17
Merit Medical Systems (MMSI) United States $5.512B 26.65
DENTSPLY SIRONA (XRAY) United States $3.117B 9.31
CONMED (CNMD) United States $1.635B 12.23
STAAR Surgical (STAA) United States $0.851B 0.00
Lifevantage (LFVN) United States $0.154B 15.90
Pro-Dex (PDEX) United States $0.138B 15.13